← Insider buys
ARQT

Arcutis Biotherapeutics, Inc. · Healthcare

Insider Masaru Matsuda sold $92K of Arcutis Biotherapeutics, Inc.

Sold$91,853
$25.00Price
3,674Shares
−3%Stake

What ARQT did after the filing

Filed Sep 18Copier in Sep 21
The stock from Mon, Sep 21 open, $25.57
+22.0%
S&P 500, same days
−0.8%

24 of 30 trading days so far, to the Oct 23 close.

Traded Wed, Sep 16. Filed Fri, Sep 18, 4:17 PM ET, after the close. Returns use the Sep 21 open and the Oct 23 close. Not investment advice.